General Information of the Compound
| Compound ID |
CP0537714
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(1R,9S,12R)-13-[8-[[1-(2,2-difluoropropyl)piperidin-4-yl]amino]-3-methyl-[1,2,4]triazolo[4,3-b]pyridazine-6-carbonyl]-12-propan-2-yl-11,13-diazatricyclo[7.3.1.02,7]trideca-2,4,6-trien-10-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H36F2N8O2
|
||||||||||||||||||
| Molecular Weight |
566.657
|
||||||||||||||||||
| Canonical SMILES |
CC(C)[C@H]1NC(=O)[C@@H]2Cc3ccccc3[C@H]1N2C(=O)c1cc(NC2CCN(CC(C)(F)F)CC2)c2nnc(C)n2n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H36F2N8O2/c1-16(2)24-25-20-8-6-5-7-18(20)13-23(27(40)33-24)38(25)28(41)22-14-21(26-35-34-17(3)39(26)36-22)32-19-9-11-37(12-10-19)15-29(4,30)31/h5-8,14,16,19,23-25,32H,9-13,15H2,1-4H3,(H,33,40)/t23-,24+,25+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
OAFNXIAXHDYYCH-ISJGIBHGSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03639, ATPase family AAA domain-containing protein 2
Protein ID: PT01462, Bromodomain-containing protein 4